Protect Patient Lives with Accurate Sepsis Testing — Every Time 

In sepsis diagnostics, your clinical lab’s precision directly affects patient survival. Discover how Tampa General Hospital integrated MDx-Chex® molecular quality controls into its BIOFIRE® BCID2 workflow — improving testing accuracy, reducing retests and accelerating life-saving diagnoses. 

Watch the on-demand webinar — available now for a limited time. 

Have questions or want to try MDx-Chex in your lab? Fill out the form and we’ll get in touch with you!

Request more information about MDx-Chex

Why Accurate Sepsis Testing Matters 

Sepsis is a time-critical condition. Every test result your lab produces influences urgent clinical decisions and patient outcomes. 

MDx-Chex quality controls are designed to help molecular diagnostic laboratories deliver reliable, reproducible results across the entire sepsis testing process. 

Using true patient-like materials and comprehensive workflow verification, MDx-Chex validates your entire testing workflow — from nucleic acid extraction to final detection — ensuring your instruments report exactly what clinicians need to diagnose and treat sepsis quickly and confidently. 

A gloved hand holds an MDx-Chex tube, an advanced molecular diagnostic control, above an open kit box containing multiple red and black-capped vials. Ideal for labs using Streck products.
Red quotation marks

“When accuracy matters, MDx-Chex delivers confidence — in our people, our instruments, and our results.” 

— Dr. Luciano Soares, Clinical Scientist, Tampa General Hospital

Key Features of MDx-Chex Controls

  • End-to-End Workflow Validation
    Confirm accuracy across all molecular testing steps to support timely, appropriate treatment decisions.
  • True Patient-Like Controls
    Built with whole, inactivated organisms in a blood-like matrix to meet CLSI, CAP and ASM guidelines.
  • Trusted Instrument Compatibility
    Optimized for use with BIOFIRE BCID2 and VERIGENE® BC-GP/BC-GN sepsis panels.